|
Index of reports
> Cases with Anaemia (235)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cyclophosphamide where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 235 Next >>
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient: male, weighing 94.0 kg (206.8 pounds)
Reactions: Intussusception, Anaemia, Chronic Obstructive Pulmonary Disease, Renal Failure Chronic
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-08-16
End date: 2012-01-03
Fludarabine Phosphate
Dosage: day1, 2, 3 q month
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-08-16
End date: 2012-01-05
Cyclophosphamide
Dosage: day1, 2, 3 q month
Indication: Chronic Lymphocytic Leukaemia
Start date: 2011-08-16
End date: 2012-01-05
Possible Cyclophosphamide side effects in 65 year old female
Reported by a physician from Japan on 2012-08-24
Patient: 65 year old female, weighing 50.2 kg (110.6 pounds)
Reactions: Weight Decreased, Blood Bilirubin Increased, Cytomegalovirus Viraemia, Headache, Pyrexia, Interstitial Lung Disease, Oedema, Thrombocytopenia, Blood Sodium Decreased, Decreased Appetite, Vomiting, Stomatitis, Pneumonia, Alanine Aminotransferase Increased, Lymphopenia, Anaemia, Febrile Neutropenia, Rash, Blood Phosphorus Decreased, Blood Potassium Decreased, Diarrhoea, Alopecia, Aspartate Aminotransferase Increased, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Prednisolone
Dosage: 1mg/kg x 1/2 week
Start date: 2011-12-13
End date: 2011-12-14
Adriamycin PFS
Dosage: 30 mg/m2 x 1/4 week
Start date: 2011-03-16
Prednisolone
Dosage: 40 mg/m2 x 1/4 week
Administration route: Oral
Start date: 2011-03-16
Prednisolone
Dosage: 2 mg/m2, 1x/day
Administration route: Oral
Start date: 2011-03-24
Vindesine Sulfate
Dosage: 2.4 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Carboplatin
Dosage: 250 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Cyclophosphamide
Dosage: 350 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Etoposide
Dosage: 100 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-24
Vincristine Sulfate
Dosage: 1 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Ranimustine
Dosage: 60 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-16
Adriamycin PFS
Dosage: 40 mg/m2 x 1/4 week
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2011-03-09
Other drugs received by patient: Mucosolvan; Lansoprazole; Sulfamethoxazole and Trimethoprim; Armodafinil; Zolpidem; Olopatadine HCL; Cefazolin Sodium; Ciprofloxacin HCL; Armodafinil; Zovirax; Magmitt; Alendronate Sodium
Possible Cyclophosphamide side effects in 67 year old female
Reported by a physician from Netherlands on 2012-08-23
Patient: 67 year old female, weighing 46.0 kg (101.2 pounds)
Reactions: Anaemia, Circulatory Collapse
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 540 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-06
Cyclophosphamide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-05
Doxorubicin Hydrochloride
Dosage: 72 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-05
Neupogen
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-06
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-05
Possible Cyclophosphamide side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Stomatitis, Anaemia, Febrile Neutropenia, Constipation, Neutrophil Count Decreased
Drug(s) suspected as cause:
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-10-27
End date: 2010-10-28
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-12-07
End date: 2010-12-07
Epirubicin Hydrochloride
Dosage: |100 mg, once
Indication: Breast Cancer
Start date: 2010-09-29
End date: 2010-09-29
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-12-07
End date: 2010-12-07
Emend
Dosage: 125 mg, once
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2010-09-29
End date: 2010-09-29
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-10-26
End date: 2010-10-26
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-10-26
End date: 2010-10-26
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-12-07
End date: 2010-12-07
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-09-30
End date: 2010-10-01
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-12-08
End date: 2010-12-09
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-10-26
End date: 2010-10-26
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-11-17
End date: 2010-11-18
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-11-16
End date: 2010-11-16
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-11-16
End date: 2010-11-16
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-11-16
End date: 2010-11-16
Cyclophosphamide
Dosage: 700 mg, once
Indication: Breast Cancer
Start date: 2010-09-29
End date: 2010-10-29
Other drugs received by patient: Granisetron Hydrochloride; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Granisetron Hydrochloride; Mucosta; Mucosta; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-22
Patient: male
Reactions: Rectal Haemorrhage, Constipation, Cardiac Disorder, Hospitalisation, Granulocytopenia, Inappropriate Antidiuretic Hormone Secretion, Thrombocytopenia, Cardiac Failure Congestive, Pneumonia, Anaemia, Pancytopenia, Atrial Fibrillation, Febrile Neutropenia, Syncope, Embolism, Sepsis, Dehydration, Asthenia, Mantle Cell Lymphoma Recurrent, Leukopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: on day 1
Indication: Diffuse Large B-Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Mantle Cell Lymphoma
Vincristine
Dosage: on day 1 (maximum dose: 2mg)
Indication: Mantle Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: on day 1
Indication: Mantle Cell Lymphoma
Leukine
Dosage: on day 9-15; 250 mcg/m2/day
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 15; as infusion
Indication: Mantle Cell Lymphoma
Possible Cyclophosphamide side effects in 56 year old female
Reported by a physician from United States on 2012-08-22
Patient: 56 year old female, weighing 91.2 kg (200.6 pounds)
Reactions: Anaemia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Paclitaxel
Dosage: 65mgm2 cyclic
Indication: Breast Cancer
Start date: 2011-02-03
End date: 2011-04-13
Pazopanib
Dosage: 400mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2011-02-03
End date: 2011-04-10
Cyclophosphamide
Indication: Breast Cancer
Start date: 2010-11-10
End date: 2011-01-12
Doxorubicin Hydrochloride
Dosage: 60mgm2 cyclic
Indication: Breast Cancer
Start date: 2010-11-10
End date: 2011-01-12
Other drugs received by patient: Armodafinil
Possible Cyclophosphamide side effects in 54 year old female
Reported by a physician from United States on 2012-08-21
Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Pancytopenia, Platelet Count Decreased, Device Related Infection, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 df, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-10
Paclitaxel
Dosage: 80 mg/m2, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Bevacizumab
Dosage: 10 mg/kg, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-10
Pegfilgrastim
Dosage: 480 mug, unk
Indication: Chemotherapy
Start date: 2011-12-22
Other drugs received by patient: Tylenol (Caplet); Emend; Levaquin; Decadron; Zofran / 00955302 /; Aloxi; Compazine
Possible Cyclophosphamide side effects in female
Reported by a physician from Netherlands on 2012-08-17
Patient: female, weighing 46.0 kg (101.2 pounds)
Reactions: Anaemia, Circulatory Collapse
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-05
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-05
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-05
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-06
Filgrastim
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-10-06
Possible Cyclophosphamide side effects in
Reported by a physician from United Kingdom on 2012-08-10
Patient:
Reactions: Diarrhoea, Anaemia, Dizziness, Pulmonary Mycosis, Lethargy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Doxorubicin HCL
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Velcade
Dosage: 2.6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Cyclophosphamide
Dosage: 1500 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-04
Prednisolone
Dosage: 100 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-07-08
Other drugs received by patient: Prednisolone; Tramadol HCL; Chlorhexidine Gluconate; Omeprazole; Itraconazole; Acyclovir; Symbicort; Montelukast; Cetraben / 01561901 /; Fluconazole; Nitrofurantoin; Citalopram Hydrobromide; NEO-Mercazole TAB; Cotrim; Ferrous Fumarate; Ventolin; Enoxaparin Sodium; Metoclopramide
Possible Cyclophosphamide side effects in 26 year old female
Reported by a physician from Japan on 2012-08-03
Patient: 26 year old female
Reactions: Enterocolitis Haemorrhagic, Cytomegalovirus Enterocolitis, Gastrointestinal Haemorrhage, Pleurisy, Anaemia, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate Sodium
Indication: Chronic Myeloid Leukaemia
Adriamycin PFS
Dosage: 35.2 mg, 1x/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Oncovin
Dosage: 1.971 mg, 1x/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Sprycel
Dosage: 70 mg
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
Start date: 2010-03-01
Cyclophosphamide
Dosage: 422.4 mg, 1x/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Other drugs received by patient: Lasix; Primperan TAB; Armodafinil; Levofloxacin; NEO-Minophagen C; Decadron Phosphate; Allopurinol
Possible Cyclophosphamide side effects in male
Reported by a pharmacist from United States on 2012-08-03
Patient: male
Reactions: Renal Failure, Anaemia, Encephalopathy, Multiple Myeloma, Hypercalcaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-02
Velcade
Indication: Multiple Myeloma
Decadron Phosphate
Indication: Multiple Myeloma
Other drugs received by patient: Hydrocodone Bitartrate; Vitamins NOS; Prochlorperazine; Tamsulosin HCL; Venlafaxine; Aspirin; Miralax; Ibuprofen (Advil); Magnesium Oxide; Omeprazole; Oxycontin; Trazodone Hydrochloride; Finasteride
Possible Cyclophosphamide side effects in female
Reported by a physician from Poland on 2012-08-02
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Retroperitoneal Mass, Vomiting, Nausea, Anaemia, Nephropathy Toxic, Folate Deficiency, Iron Deficiency, Herpes Zoster, Vitamin B12 Increased, Asthenia, Beta 2 Microglobulin Increased, Leukopenia
Drug(s) suspected as cause:
Vincristine
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Prednisone
Administration route: Oral
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Cyclophosphamide
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Doxorubicin Hydrochloride
Indication: Lymphoma
Start date: 2011-06-22
End date: 2011-10-27
Other drugs received by patient: Heviran; Tamoxifen Citrate
Possible Cyclophosphamide side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 46 year old female
Reactions: Pain in Extremity, Unresponsive To Stimuli, Anaemia, Pallor, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Diarrhoea Haemorrhagic, Blood Culture Positive, Small Intestinal Haemorrhage, Asthenia, Apnoea, Hepatosplenomegaly, Candidiasis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Oncovin
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Idarubicin HCL
Dosage: 12 mg/d/m2 (1 cycle)
Rituximab
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Melphalan Hydrochloride
Vorinostat
Dosage: 1 cycle
Administration route: Oral
Cyclophosphamide
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Rituximab
Carmustine
Cytarabine
Dosage: 1.5 g/d/m2 (1 cycle)
Possible Cyclophosphamide side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30
Patient: 46 year old female
Reactions: Pain in Extremity, Anaemia, Pyrexia, Pallor, Stem Cell Transplant, Pulmonary Haemorrhage, Zygomycosis, Skin Discolouration, Blood Culture Positive, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Asthenia, Hepatosplenomegaly, Candidiasis, Cough
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Carmustine
Idarubicin HCL
Dosage: 12 mg/d/m2 (1 cycle)
Rituximab
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Cytarabine
Melphalan Hydrochloride
Cytarabine
Dosage: 1.5 g/d/m2 (1 cycle)
Oncovin
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Rituximab
Doxorubicin Hydrochloride
Dosage: 8 courses
Indication: Diffuse Large B-Cell Lymphoma
Vorinostat
Dosage: 1 cycle
Administration route: Oral
Possible Cyclophosphamide side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-30
Patient: 70 year old female
Reactions: Renal Impairment, Hyperkalaemia, Anaemia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Possible Cyclophosphamide side effects in 24 year old female
Reported by a consumer/non-health professional from United States on 2012-07-30
Patient: 24 year old female, weighing 51.0 kg (112.2 pounds)
Reactions: Abdominal Pain, Hyperkalaemia, Disseminated Intravascular Coagulation, Gastrointestinal Necrosis, Acidosis, Nephrolithiasis, Skin Discolouration, Ecchymosis, Clostridial Infection, Emphysema, White Blood Cell Count Decreased, Hypotension, Anaemia, Condition Aggravated, Soft Tissue Infection, Sepsis, Flank Pain, Colitis, Cardiac Arrest, Sinus Tachycardia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sprycel
Dosage: last dose on 26jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Cytarabine
Dosage: last dose:17jun12 route:intra ommya
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Vincristine Sulfate
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Filgrastim
Dosage: last dose:18jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
End date: 2012-01-01
Leucovorin Calcium
Dosage: last dose :21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methotrexate
Dosage: last dose:13jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Dexamethasone
Dosage: last dose:16jun12
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Doxorubicin HCL
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Mesna
Dosage: last dose:17jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Cyclophosphamide
Dosage: last dose on 16jun12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Methylprednisolone
Dosage: last dose:21may12
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-05-17
Possible Cyclophosphamide side effects in female
Reported by a physician from United Kingdom on 2012-07-27
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Anaemia, Neutropenia, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Prednisone
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Furosemide
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-12-23
Possible Cyclophosphamide side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient: 46 year old female
Reactions: Pancreatic Infarction, Unresponsive To Stimuli, Myelodysplastic Syndrome, Pyrexia, Pallor, Cerebral Haemorrhage, Skin Discolouration, Diarrhoea Haemorrhagic, Small Intestinal Haemorrhage, Apnoea, Thrombocytopenia, Cough, Candidiasis, Hepatosplenomegaly, Dyspnoea, Pain in Extremity, Anaemia, Pulmonary Haemorrhage, Zygomycosis, Diarrhoea, Hemisensory Neglect, Lung Infiltration, Asthenia, Hepatic Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Etoposide
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Idarubicin HCL
Dosage: 12 mg/m2, unk
Indication: Myelodysplastic Syndrome
Carmustine
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Suberoylanilide Hydroxamic Acid
Dosage: 500 mg, tid
Administration route: Oral
Indication: Myelodysplastic Syndrome
Cytarabine
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Oncovin
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Radiotherapy
Possible Cyclophosphamide side effects in 26 year old female
Reported by a physician from Japan on 2012-07-27
Patient: 26 year old female
Reactions: Enterocolitis Haemorrhagic, Cytomegalovirus Enterocolitis, Gastrointestinal Haemorrhage, Pleurisy, Anaemia, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 422.4 mg/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Adriamycin PFS
Dosage: 35.2 mg/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Methotrexate Sodium
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Sprycel
Dosage: 70 mg, 2x/day
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
Start date: 2010-03-01
End date: 2010-08-04
Oncovin
Dosage: 1.971 mg/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Other drugs received by patient: NEO-Minophagen C; Decadron; Primperan TAB; Diflucan; Allopurinol; Lasix; Levofloxacin
Possible Cyclophosphamide side effects in
Reported by a physician from Italy on 2012-07-27
Patient:
Reactions: Anaemia, Skin Toxicity, Febrile Neutropenia, Mucosal Inflammation, Neurotoxicity, Respiratory Failure, Sepsis, Neutropenia, Cardiotoxicity, Septic Shock, Thrombocytopenia, Myocardial Infarction, Diffuse Large B-Cell Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Epirubicin Hydrochloride
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Prednisone and Prednisone
Indication: Diffuse Large B-Cell Lymphoma
Mabthera
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Indication: Diffuse Large B-Cell Lymphoma
Possible Cyclophosphamide side effects in 26 year old female
Reported by a physician from Japan on 2012-07-24
Patient: 26 year old female
Reactions: Enterocolitis Haemorrhagic, Gastrointestinal Haemorrhage, Cytomegalovirus Enterocolitis, Pleurisy, Anaemia, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 422.4 mg/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Adriamycin PFS
Dosage: 35.2 mg/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Methotrexate Sodium
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Sprycel
Dosage: 70 mg, 2x/day
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
Start date: 2010-03-01
End date: 2010-08-04
Oncovin
Dosage: 1.971 mg/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Other drugs received by patient: Decadron; Diflucan; Allopurinol; Levofloxacin; Lasix; Primperan TAB; NEO-Minophagen C
Possible Cyclophosphamide side effects in female
Reported by a consumer/non-health professional from United Kingdom on 2012-07-23
Patient: female, weighing 67.0 kg (147.4 pounds)
Reactions: Small Intestinal Obstruction, Anaemia, Febrile Neutropenia, Device Related Infection
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Start date: 2012-04-26
Cyclophosphamide
Start date: 2012-04-26
Prednisolone
Administration route: Oral
Start date: 2012-04-26
Vincristine
Start date: 2012-04-26
Possible Cyclophosphamide side effects in
Reported by a physician from Italy on 2012-07-20
Patient:
Reactions: Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Diffuse Large B-Cell Lymphoma Recurrent, Mucosal Inflammation, Neurotoxicity, Sepsis, Adverse Event, Cardiotoxicity, Neutropenia, Thrombocytopenia, Diffuse Large B-Cell Lymphoma, Lymphoma, Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 750 mg/m2 on day 1 for chop and 750 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: 50 mg/m2 on day 1 for chop and 50 mg/m2 on day 2 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: 375 mg/m2 on day 1 for r-chop
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: 1.4 mg/m2 on day 1 for chop and 1.4 mg/m2 on day 2 for r-chop upto a maximum dose of 2 mg
Indication: Diffuse Large B-Cell Lymphoma
Prednisone
Dosage: 100 mg on days 1-5 for chop and r-chop
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Neupogen
Possible Cyclophosphamide side effects in 26 year old female
Reported by a physician from Japan on 2012-07-19
Patient: 26 year old female
Reactions: Enterocolitis Haemorrhagic, Cytomegalovirus Enterocolitis, Gastrointestinal Haemorrhage, Anaemia, Pleurisy, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 35.2 mg, 1x/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Sprycel
Dosage: 70 mg
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
Start date: 2010-03-01
Methotrexate Sodium
Indication: Chronic Myeloid Leukaemia
Cyclophosphamide
Dosage: 422.4 mg, 1x/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Oncovin
Dosage: 1.971 mg, 1x/day
Indication: Chronic Myeloid Leukaemia
Start date: 2010-02-26
End date: 2010-03-02
Other drugs received by patient: Decadron; Allopurinol; Primperan TAB; Lasix; Levofloxacin; NEO-Minophagen C; Diflucan
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Possible Cyclophosphamide side effects in 69 year old female
Reported by a pharmacist from Switzerland on 2012-07-16
Patient: 69 year old female
Reactions: Interstitial Lung Disease, Anaemia, Lymphopenia, Neutrophil Count Decreased, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-01-01
End date: 2012-03-01
Taxol
Start date: 2012-01-02
End date: 2012-05-10
Epirubicin Hydrochloride
Start date: 2012-01-01
End date: 2012-03-01
Herceptin
Start date: 2012-01-02
End date: 2012-05-10
Other drugs received by patient: Piracetam; Phlebostasin; Betaserc; Amlodipine
Possible Cyclophosphamide side effects in 68 year old female
Reported by a pharmacist from Switzerland on 2012-07-09
Patient: 68 year old female
Reactions: Interstitial Lung Disease, Anaemia, Lymphopenia, Neutrophil Count Decreased, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Taxol
Dosage: unk
Indication: Breast Cancer in Situ
Start date: 2012-01-02
End date: 2012-03-01
Cyclophosphamide
Dosage: 900 mg, cyclic
Indication: Breast Cancer in Situ
Start date: 2012-01-01
End date: 2012-03-01
Taxol
Dosage: 120 mg, weekly
Start date: 2012-03-29
End date: 2012-05-10
Herceptin
Dosage: unk
Indication: Breast Cancer in Situ
Start date: 2012-01-02
End date: 2012-03-01
Herceptin
Dosage: 240 mg, 1x/day
Start date: 2012-03-29
End date: 2012-03-29
Herceptin
Dosage: 120 mg, weekly
Start date: 2012-04-05
End date: 2012-05-10
Epirubicin Hydrochloride
Dosage: 135 mg, cyclic
Indication: Breast Cancer in Situ
Start date: 2012-01-01
End date: 2012-03-01
Other drugs received by patient: Betaserc; Fragmin; Phlebostasin; Pantoprazole Sodium; Betaserc; Nootropil; Phlebostasin; Pantoprazole Sodium; Nootropil; Amlodipin Mepha
Possible Cyclophosphamide side effects in male
Reported by a consumer/non-health professional from Germany on 2012-07-09
Patient: male
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-04-06
End date: 2012-04-06
Rituximab
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-02
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Prednisolone
Dosage: 500 mg, qd
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-06
Other drugs received by patient: Novalgin / 00169801 /; Morphine Sulfate; Pantoprazole; Dipyrone TAB; Metoclopramide; Acyclovir
Possible Cyclophosphamide side effects in 65 year old female
Reported by a physician from Netherlands on 2012-07-06
Patient: 65 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 88 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Vincristine
Dosage: 2 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Neulasta
Dosage: 6 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-26
Rituximab
Dosage: 660 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Cyclophosphamide
Dosage: 1310 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Possible Cyclophosphamide side effects in female
Reported by a consumer/non-health professional from Germany on 2012-07-06
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: B-Cell Lymphoma, Anaemia, Urinary Incontinence, Abnormal Behaviour, Pulmonary Embolism, Cognitive Disorder, Pyrexia, Fall, Peripheral Sensory Neuropathy, Post Transplant Lymphoproliferative Disorder, Klebsiella Infection, Cytokine Release Syndrome, Cytomegalovirus Infection, Neutrophil Toxic Granulation Present, Traumatic Haematoma, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg, bid
Start date: 2009-07-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-07
Vincristine
Dosage: 2 mg, once
Start date: 2009-06-23
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-06-23
Filgrastim
Dosage: 3000 iu, unk
Start date: 2009-07-26
End date: 2009-08-27
Campath
Dosage: 20 mg, qd
Start date: 2009-07-07
Vincristine
Dosage: 1 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-20
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-09-11
Campath
Dosage: 30 mg, qd
Start date: 2009-08-06
End date: 2009-08-06
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-21
Doxorubicin HCL
Dosage: 80 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-07
Filgrastim
Dosage: unk on days 4 through 13 of course 5
Start date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-21
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-15
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-08-06
End date: 2009-08-10
Filgrastim
Dosage: unk on days 4 through 12 of course 6
Start date: 2009-09-08
Campath
Dosage: 30 mg, qd
Start date: 2009-09-11
End date: 2009-10-22
Cyclophosphamide
Dosage: 1250 mg, once
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-09-08
End date: 2009-09-08
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-23
Filgrastim
Dosage: unk on days 4, 5, 6 of course 1
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Filgrastim
Dosage: unk on days 4 through 15 of course 2
Start date: 2009-07-07
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-07-23
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-07
Filgrastim
Dosage: unk on days 4 through 8 and day 13 of course 3
Start date: 2009-07-23
Filgrastim
Dosage: unk on days 6 + 7 and days 9 through 12 of course 4
Start date: 2009-08-06
Doxorubicin HCL
Dosage: 80 mg, once
Start date: 2009-08-20
Vincristine
Dosage: 2 mg, once
Start date: 2009-07-21
Vincristine
Prednisone
Dosage: 100 mg, qd for 5 days
Administration route: Oral
Start date: 2009-07-23
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Start date: 2009-09-08
End date: 2009-09-08
Campath
Dosage: 10 mg, qd
Indication: Peripheral T-Cell Lymphoma Unspecified
Start date: 2009-06-23
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-07-07
Cyclophosphamide
Dosage: 1200 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Vincristine
Dosage: 2 mg, once
Start date: 2009-08-06
End date: 2009-08-20
Filgrastim
Dosage: 30000 iu, qd
Start date: 2009-09-11
End date: 2009-09-19
Other drugs received by patient: Enoxaparin Sodium; Enoxaparin Sodium; Ganciclovir; Metoprolol Tartrate; Trimethoprim + Sulfamethoxazole; Dexamethasone; Antibiotics; Torsemide; Fluticasone Propionate W; Fondaparinux Sodium; Pantoprazole; Ganciclovir; Spiriva
Page 1 Next >>
|
